Ishita Drugs & Industries Ltd.
BSE: 524400
₹83.00
₹2.00
(2.47%)
As on 08-May-2026IST
Market cap
₹25 Cr
Revenue (TTM)
₹16 Cr
P/E Ratio
27.9
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
8.4 %
-
ROCE
10 %
-
Industry P/E
31.48
-
EV/EBITDA
16
-
Debt to Equity
0.4
-
Book Value
₹38.1
-
EPS
₹3
-
Face value
10
-
Shares outstanding
2,990,300
10 Years Aggregate
CFO
₹1.32 Cr
EBITDA
₹6.95 Cr
Net Profit
₹5.29 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ishita Drugs
| 3.8 | 3.1 | 13.7 | 10.8 | 16.3 | 22.6 | 20.2 |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Ishita Drugs
| -16.0 | 21.1 | 39.0 | 11.9 | 47.1 | 163.5 | -25.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ishita Drugs
|
83.0 | 24.8 | 16.2 | 0.9 | 5.3 | 8.1 | 27.9 | 2.2 |
| 3,035.0 | 37,883.0 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 35.9 | 8.4 | |
| 8,493.0 | 21,223.1 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.6 | 25.5 | |
| 1,856.3 | 14,118.0 | 2,089.5 | 622.0 | 31.3 | 20.4 | 23 | 4.2 | |
| 1,386.1 | 19,212.4 | 3,078.2 | 469.4 | 26.4 | 14.9 | 44.5 | 5.3 | |
| 2,149.8 | 34,550.6 | 4,193.0 | 753.8 | 22.7 | 20.8 | 45.8 | 8.6 | |
| 4,818.8 | 22,009.5 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.8 | 5.5 | |
| 5,355.0 | 8,882.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 30.3 | 12.7 | |
| 437.0 | 8,532.3 | 1,432.0 | 149.0 | 19.1 | 7.9 | 56.9 | 3.4 | |
| 1,156.9 | 10,653.8 | 4,725.6 | 528.7 | 14.9 | 20.7 | 20.8 | 3.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Ishita Drugs
Ishita Drugs & Industries Limited manufactures and sells active pharma ingredients and drug intermediates in India. It offers active pharma ingredients, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics,... iodides and citrates, food additives/excipients, and others; fine chemicals; and drug intermediaries, as well as finished dosage forms. The company also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. It serves regulatory authorities and pharmaceutical companies. The company exports its products to approximately 25 countries. Ishita Drugs & Industries Limited was incorporated in 1992 and is based in Ahmedabad, India. Read more
-
Incorporated
1992
-
Chairman
--
-
Managing Director
Jagdish Agrawal
-
Headquarters
Ahmedabad Dist, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Ishita Drugs
What is the current share price of Ishita Drugs & Industries Ltd Today?
The share price of Ishita Drugs & Industries Ltd is ₹83.00 (BSE) as of 08-May-2026 IST. Ishita Drugs & Industries Ltd has given a return of 16.32% in the last 3 years.
What is the current PB & PE ratio of Ishita Drugs & Industries Ltd?
The P/E ratio of Ishita Drugs & Industries Ltd is 27.95 times as on 08-May-2026, a 11 discount to its peers’ median range of 31.48 times.
The P/B ratio of Ishita Drugs & Industries Ltd is 2.18 times as on 08-May-2026, a 54 discount to its peers’ median range of 4.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
27.05
|
2.18
|
|
2024
|
26.20
|
1.98
|
|
2023
|
25.59
|
1.61
|
|
2022
|
15.36
|
1.44
|
|
2021
|
10.81
|
1.15
|
What is the 52 Week High and Low of Ishita Drugs & Industries Ltd?
The 52-week high and low of Ishita Drugs & Industries Ltd are Rs 90.85 and Rs 66.00 as of 08-May-2026.
What is the market cap of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd has a market capitalisation of ₹ 25 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Ishita Drugs & Industries Ltd?
Before investing in Ishita Drugs & Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.